Next Generation News and Research

RSS

BUSM assistant professor awarded $2.1 million for peripheral artery disease research

Peripheral artery disease (PAD) is a major cause of limb loss. It is estimated that PAD affects between 8.5 and 12 million Americans, with a prevalence that has increased by about 25 percent over the preceding decade.

21 Sep 2021

KU researcher wins $1.25 million award to investigate the vital role of sex hormones in tissue repair

Our ability to heal and regenerate new tissue after an injury has much to do with biological sex. For instance, following menopause, the loss of sex-hormone signaling in women can lead to degenerative diseases such as osteoporosis and osteoarthritis, where bone and cartilage degrade and become more delicate and brittle because of tissue loss.

21 Sep 2021

Sunitinib extends progression-free survival in patients with rare neuroendocrine tumor, study shows

The first randomized study in malignant pheochromocytoma and paraganglioma (MPP) has found that sunitinib prolongs progression-free survival (PFS) by more than five months.

20 Sep 2021

Analysis of 2021 Ebola outbreak reveals long-term dormant infections

Guinea recently experienced its second outbreak of the Ebola virus disease within the last decade.

19 Sep 2021

Researchers report on under-sequenced region of S gene of the SARS-CoV2 Delta variant

In a recent study, Swiss researchers use improved techniques to understand the biological significance behind the Delta variant.

19 Sep 2021

Researchers investigate the sex differences among patients with cardiac sarcoidosis

Researchers from the University of Minnesota Medical School investigated the sex differences among patients with cardiac sarcoidosis, a multisystem, granulomatous disorder.

16 Sep 2021

Grouping EGFR mutations provides an accurate way to match lung cancer patients to the right drugs

Researchers from The University of Texas MD Anderson Cancer Center have discovered that grouping epidermal growth factor receptor (EGFR) mutations by structure and function provide an accurate framework to match patients with non-small cell lung cancer (NSCLC) to the right drugs.

16 Sep 2021

A sweet pill to swallow: oral nucleoside analog of Remdesivir improved SARS-CoV-2 pathogenesis in mice

A new study focused on in vitro antiviral activity in various cell models and in vivo therapeutic efficacy of oral GS-621763 in a mouse model of SARS-CoV-2 pathogenesis.

15 Sep 2021

Study reveals role of globalization and zoonosis in the emergence and spread of SARS-CoV-2 variants

A recent study aimed to use their own classification of different SARS-CoV-2 lineages that would help monitor their genetic features and geographical origins.

14 Sep 2021

Jumpcode Genomics and TGen collaborate on genomic sequencing of SARS-CoV-2

Jumpcode Genomics, a genome technology platform company focused on improving the understanding of human biology, announced today a collaboration with the Translational Genomics Research Institute (TGen), an affiliate of City of Hope, to aid investigations into the genomic epidemiology of SARS-CoV-2, the virus that causes COVID-19.

14 Sep 2021

HORIBA UK launches new generation Microsemi CRP near-patient haematology analyser

Northampton, UK, 14th September 2021 – HORIBA UK Limited has launched its new generation Microsemi CRP point-of-care haematology analyser.

From HORIBA Scientific UK 14 Sep 2021

Digital spatial profiling of individual glomeruli from HIV and COVID-19 patients

Now, a new study posted to the bioRxiv* server by scientists from the University of Washington explores the use of NanoString’s GeoMx digital spatial profiling (DSP) to investigate CG caused by HIV and SARS-Cov-2 infections.

14 Sep 2021

New precision-guided sterile insect technique designed to control disease-spreading mosquitoes

Leveraging advancements in CRISPR-based genetic engineering, researchers at the University of California San Diego have created a new system that restrains populations of mosquitoes that infect millions each year with debilitating diseases.

11 Sep 2021

New statement on COVAX global supply forecast for 2021 and early 2022

Twelve months ago, the world came together to support COVAX, a multilateral initiative aimed at guaranteeing global access to life-saving COVID-19 vaccines.

10 Sep 2021

Cryopreservation Excipient for Cell Therapies

AMSBIO has launched STEM-CELLBANKER® EX - a next generation cryopreservation product that eliminates the need for the traditional washing steps required in cell therapy product development.

From AMS Biotechnology 10 Sep 2021

No evidence of pre-existing antibody and B cell immunity against SARS-CoV-2 in unexposed adults

A group of researchers analyzed the B cell response to SARS-CoV-2 in unexposed individuals.

10 Sep 2021

Researchers develop the smallest CRISPR to date for genome editing

A compact and efficient CRISPR-Cas system, named CasMINI, could be broadly useful for cell-engineering and gene-therapy applications because it is easier to deliver into cells. The findings appear in a study publishing September 3 in the journal Molecular Cell.

4 Sep 2021

Don and Karen Cohn's $2.5 million gift supports UC San Diego Health neurosurgery program

Don and Karen Cohn have given $2.5 million to create the Don and Karen Cohn Chancellor's Endowed Chair in Neurosurgery at University of California San Diego School of Medicine.

4 Sep 2021

Study: Epilepsy brain implant does not induce changes to patients' personalities or self-perceptions

A next-generation brain implant currently in clinical use for treating refractory epilepsy – to help prevent symptoms including seizures – does not induce changes to patients' personalities or self-perceptions, a new study of patient experiences shows.

3 Sep 2021

UTSA receives $3.2 million CPRIT grant for developing new approach to fight against cancer

The University of Texas at San Antonio has been awarded a five-year $3.2 million grant from the Cancer Prevention & Research Institute of Texas.

2 Sep 2021

Next Generation News and Research

BUSM assistant professor awarded $2.1 million for peripheral artery disease research

KU researcher wins $1.25 million award to investigate the vital role of sex hormones in tissue repair

Sunitinib extends progression-free survival in patients with rare neuroendocrine tumor, study shows

Analysis of 2021 Ebola outbreak reveals long-term dormant infections

Researchers report on under-sequenced region of S gene of the SARS-CoV2 Delta variant

Researchers investigate the sex differences among patients with cardiac sarcoidosis

Grouping EGFR mutations provides an accurate way to match lung cancer patients to the right drugs

A sweet pill to swallow: oral nucleoside analog of Remdesivir improved SARS-CoV-2 pathogenesis in mice

Study reveals role of globalization and zoonosis in the emergence and spread of SARS-CoV-2 variants

Jumpcode Genomics and TGen collaborate on genomic sequencing of SARS-CoV-2

HORIBA UK launches new generation Microsemi CRP near-patient haematology analyser

Digital spatial profiling of individual glomeruli from HIV and COVID-19 patients

New precision-guided sterile insect technique designed to control disease-spreading mosquitoes

New statement on COVAX global supply forecast for 2021 and early 2022

Cryopreservation Excipient for Cell Therapies

No evidence of pre-existing antibody and B cell immunity against SARS-CoV-2 in unexposed adults

Researchers develop the smallest CRISPR to date for genome editing

Don and Karen Cohn's $2.5 million gift supports UC San Diego Health neurosurgery program

Study: Epilepsy brain implant does not induce changes to patients' personalities or self-perceptions

UTSA receives $3.2 million CPRIT grant for developing new approach to fight against cancer

Industry Focus eBook - Cell & Gene Therapy (1st Edition) eBook

Advancing Intracellular Delivery with LumiPore®

How ELRIG Is Helping Mid-Career Scientists Navigate Leadership, Career Change and Redundancy

The role of UV-Vis in biopharma QC

Latest News